NEWS: PrimeVigilance Receives Queen’s Award for Enterprise Recognition of Substantial Growth and Commercial Success

Guildford, UK – 21 April 2014; PrimeVigilance Limited (PrimeVigilance), the specialist pharmacovigilance service provider, has been honoured with the Queen’s Award for Enterprise 2014 in the International Trade Category. PrimeVigilance has received the accolade – which is the highest official award for business success in the UK – in recognition of achieving substantial overseas earnings with growth and commercial success for the last six years.
PrimeVigilance is a leader in providing pharmacovigilance and medical information services for national and multi-national pharmaceutical companies worldwide. It has clients based in Europe, North America, Australia and Asia/Pacific Rim providing a global service that currently covers more than 100 countries and over 150 medicinal products.
PrimeVigilance has been awarded the Queen’s Award for International Trade for outstanding growth in overseas earnings of 173% over the last three years. In addition, the company has entered a number of new markets in this period including Australia, Germany, Spain, Switzerland and the Scandinavian countries.
Neil Clark, Chief Executive Officer of PrimeVigilance commented, “PrimeVigilance has grown substantially since it was founded six years ago and this award is testament to the high quality service we provide to our customers around the world. The Queen’s Award is a great honour not just for the company but for all of our individual employees internationally who have helped contribute to the company’s success. We look forward to building on our success and achieving further growth in the future.”
The Queen’s Awards for Enterprise is a prestigious awards programme for British businesses and organisations that excel at trade, innovation or sustainable development. The awards are made annually by HM The Queen, and are only given for the highest levels of excellence demonstrated in each category. They are judged to a demanding level and winners receive a number of benefits and worldwide recognition.
****

Note to Editors:

About PrimeVigilance Ltd
The pharmacovigilance (PV) services offered by PrimeVigilance cover all the regulatory and scientific elements of PV required to obtain and maintain product licences for medicines within Europe: Qualified Person, Risk Management Planning (RMP), and a compliant PV System with consistent Adverse Event data capture, robust Quality Management, expedited reporting, preparation of Periodic Safety Update Reports, literature screening, safety signal detection and evaluation, benefit-risk assessment, compliance auditing, support during crisis and various ad hoc assignments. PrimeVigilance also offers fully integrated international Medical Information services.
PrimeVigilance has grown organically since 2008 and now has over 100 staff employed in its main offices in Guildford UK, and Zagreb, Croatia, as well as an international network of consultants. PrimeVigilance is currently providing services across more than 100 countries.
For further information please visit www.primevigilance.com or alternatively please contact:
 Neil Clark, CEO
Phone: +44 (0) 1225 731349
E-mail: neil.clark@primevigilance.com
 
Hume Brophy
Mary Clark, Supriya Mathur, Hollie Vile
Phone: + 44 203 440 5654
E-mail: healthcareteam@humebrophy.com